WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004100945) USE OF PHTHALIDE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES MELLITUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/100945    International Application No.:    PCT/EP2004/004768
Publication Date: 25.11.2004 International Filing Date: 05.05.2004
IPC:
A61K 31/343 (2006.01)
Applicants: DSM IP ASSETS B.V. [NL/NL]; Het Overloon 1, NL-6411 TE Heerlen (NL) (For All Designated States Except US).
WANG, Ying [CN/CH]; (CH) (For US Only).
DE SAIZIEU, Antoine [FR/FR]; (FR) (For US Only).
SCHÜLER, Göde [DE/DE]; (DE) (For US Only).
D'ORAZIO, Daniel [CH/CH]; (CH) (For US Only).
RÄDERSTORFF, Daniel [FR/FR]; (FR) (For US Only).
WOLFRAM, Swen [DE/DE]; (DE) (For US Only).
WEBER, Peter [DE/DE]; (DE) (For US Only).
TEIXEIRA, Sandra [PT/US]; (US) (For US Only)
Inventors: WANG, Ying; (CH).
DE SAIZIEU, Antoine; (FR).
SCHÜLER, Göde; (DE).
D'ORAZIO, Daniel; (CH).
RÄDERSTORFF, Daniel; (FR).
WOLFRAM, Swen; (DE).
WEBER, Peter; (DE).
TEIXEIRA, Sandra; (US)
Agent: SCHWANDER, Kuno, Josef; Roche Vitamins Ltd., Wurmisweg 576, CH-4303 Kaiseraugst (CH)
Priority Data:
03010804.7 14.05.2003 EP
Title (EN) USE OF PHTHALIDE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES MELLITUS
(FR) UTILISATION DE DERIVES PHTALIDES POUR ASSURER LE TRAITEMENT ET LA PROPHYLAXIE DU DIABETE SUCRE
Abstract: front page image
(EN)The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.
(FR)L'invention concerne l'utilisation d'un composé, en tant qu'agent efficace, pour assurer la prophylaxie ou le traitement du diabète sucré chez un mammifère. Lesdits composés sont sélectionnés dans le groupe des dérivés phtalides et présente d'excellents effets en termes d'abaissement du glucose dans le sang et s'avèrent de ce fait des agents efficaces dans la prophylaxie ou le traitement du diabète sucré chez les mammifères.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)